Physician profile
Jeffrey Chang
NPI 1154456226
$1,094.46
in general payments reported to CMS, 2019-2025
9 companies · $368 in 2025
The $368 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2023: $212 · 2024: $135 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $304.24 | 2019-2025 | Constellation |
| Regeneron Healthcare Solutions, INC. | $144.84 | 2019-2025 | Eylea Hd |
| Regeneron Pharmaceuticals, INC. | $124.15 | 2023 | |
| Genentech USA, INC. | $115.41 | 2024 | Vabysmo |
| Ani Pharmaceuticals, INC. | $112.03 | 2025 | Purified Cortrophin Gel, Yutiq, Iluvien |
| Novartis Pharmaceuticals Corporation | $108.74 | 2019 | |
| Apellis Pharmaceuticals, INC. | $87.51 | 2023 | Syfovre |
| Astellas Pharma US INC | $78.19 | 2025 | Izervay |
| Alimera Sciences, INC. | $19.35 | 2024 | Yutiq, Iluvien |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.